TGFB1 and neuroblastoma: Addition of recombinant TGF-β1 to in vitro co-cultures of neuroblastoma tumoroids and primed healthy donor NK cells significantly reduced tumor killing and granzyme B production by NK cells, whereas blockade of TGF-β increased cytotoxicity (Figures 4I and 4J).